Authors: Langen, KJ Bonnie, R Muhlensiepen, H Jansen, P Broer, S Holschbach, M Coenen, HH

Citation: Kj. Langen et al., 3-[I-123]iodo-alpha-methyl-L-tyrosine transport and 4F2 antigen expressionin human glioma cells, NUCL MED BI, 28(1), 2001, pp. 5-11

Authors: Langen, KJ Muhlensiepen, H Holschbach, M Hautzel, H Jansen, P Coenen, HH

Citation: Kj. Langen et al., Transport mechanisms of 3-[I-123]Iodo-alpha-methyl-L-tyrosine in a human glioma cell line: Comparison with [H-3-methyl]-L-methionine, J NUCL MED, 41(7), 2000, pp. 1250-1255

Authors: Noll, T Muhlensiepen, H Engels, R Hamacher, K Papaspyrou, M Langen, KJ Biselli, M

Citation: T. Noll et al., A cell-culture reactor for the on-line evaluation of radiopharmaceuticals:Evaluation of the lumped constant of FDG in human glioma cells, J NUCL MED, 41(3), 2000, pp. 556-564

Authors: Weber, S Bauer, A Herzog, H Kehren, F Muhlensiepen, H Vogelbruch, J Coenen, HH Zilles, K Halling, H

Citation: S. Weber et al., Recent results of the TierPET scanner, IEEE NUCL S, 47(4), 2000, pp. 1665-1669

Authors: Rosch, F Herzog, H Stolz, B Brockmann, J Kohle, M Muhlensiepen, H Marbach, P Muller-Gartner, HW

Citation: F. Rosch et al., Uptake kinetics of the somatostatin receptor ligand [Y-86]DOTA-DPhe(1)-Tyr(3)-octreotide ([Y-86]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the Y-90-labelled analogue, EUR J NUCL, 26(4), 1999, pp. 358-366